Article
LncRNA NORAD engages in psoriasis by binding to miR-26a to regulate keratinocyte proliferation
24 Mar 2021
Abstract excerpt
Background Psoriasis is a chronic, inflammatory skin disease. It was reported that lncRNA Non-coding RNA-activated by DNA damage (NORAD) has potential regulatory effects on skin diseases. Our previous studies found that lncRNA NORAD was highly expressed and its potential target miR-26a was down-regulated in psoriasis model mice. Here, we aimed to investigate the role of NORAD in the development of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
